Clinical TrialsSearch results
Number of results: 68732
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- WS-01 Investigator-initiated clinical trial
- patients with ischemic stroke or TIA attributable to intracranial atherosclerotic disease with >= 50% stenosis, refractory to medical treatment.
- Nobuyuki Sakai, Kobe City Hospital Organization Kobe City Medical Center General Hospital
- 2009-08-18
Completed
- Wristband type continuous pulse measurement device with artificial intelligence for early detection of paroxysmal atrial fibrillation
- Cardiovascular disease that needs surgery
- Inui Tomohiko
- 2020-05-13
Other
- Wrist ICT-Based Sleep and CircaDian BlOod Pressure Monitoring Program - Night blood pressure registry: [WISDOM-Night Registry]
- myocardial infarction, angina pectoris, heart failure, cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, aortic dissection, peripheral arterial disease, hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease, sleep apnea syndrome, hyperuricemia
- Jichi Medical University School of Medicine
- 2021-03-15
Other
- Wrinkle-improving effect of cosmetcic gel containing "Immortalized Human Tooth Pulp Stem Cell Conditioned Media" and "Human Cord Blood Stem Cell Conditioned Media"
- Healthy adult female
- Japan Clinical Trial Association
- 2023-07-21
Other
- Wrinkle-improving effect of an all-in-one gel containing "Immortalized Human Tooth Pulp Stem Cell Conditioned Media" and "Human Cord Blood Stem Cell Conditioned Media"
- Healthy adult female
- Japan Clinical Trial Association
- 2023-04-04
Other
- Wrinkle prevention effect by whitening serum
- Healthy adult female
- Japan Clinical Trial Association
- 2019-11-25
Recruiting
- WRAP study
- Pancreatic body/tail region disease
- Takahashi Yu
- 2024-06-15
Other
- WP-2011
- Cataract
- Ichikawa Kazuo
- 2021-04-12
Other
- WP-1303 Phase III long-term study
- Japanease patients with POAG, normal-tension glaucoma, exfoliation glaucoma, pigmentary glaucoma or OH
- Wakamoto pharmaceutical Co., Ltd
- 2018-12-03
Other
- WP-1303 Phase 3 comparison study
- primary open-angle glaucoma, ocular hypertension
- Wakamoto pharmaceutical Co., Ltd
- 2019-08-20